Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950131-96-001201
Filing Date
1996-03-22
Accepted
1996-03-22 00:00:00
Documents
11
Period of Report
1995-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 92245
2 RETIREMENT, SEPARATION AGREEMENT AND RELEASE EX-10.9 27874
3 TERMINATION AGREEMENT WITH LORI-JEAN GILLE EX-10.13 24623
4 TERMINATION AGREEMENT WITH JON C. LEE EX-10.14 24289
5 TERMINATION AGREEMENT WITH RAJESH C. SHROTRIYA EX-10.15 25119
6 MANUFACTURING AGREEMENT WITH GLOBAL PHARM, INC. EX-10.25 83121
7 COMPUTATION OF NET LOSS PER COMMON SHARE EX-11 1408
8 1995 ANNUAL REPORT TO SHAREHOLDERS EX-13 78552
9 CONSENT OF KPMG PEAT MARWICK LLP EX-23 1082
10 POWERS OF ATTORNEY EX-24 2739
11 FINANCIAL DATA SCHEDULE EX-27 2584
  Complete submission text file 0000950131-96-001201.txt   366392
Mailing Address OPUS CENTER 9900 BREN ROAD EAST SUITE 300E MINNEAPOLIS MN 55343
Business Address 9900 BREN RD EAST STE 300E C/O OPUS CENTER MINNETONKA MINNESOTA MINNEAPOLIS MN 55343 6129357335
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-10736 | Film No.: 96537686
SIC: 2834 Pharmaceutical Preparations